Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Innocent Mushi is active.

Publication


Featured researches published by Innocent Mushi.


Bioorganic & Medicinal Chemistry Letters | 2008

Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity.

Monika Ermann; Doris Riether; Edward Walker; Innocent Mushi; James Edward Jenkins; Beatriz Noya-Marino; Mark L. Brewer; Malcolm Taylor; Patricia Amouzegh; Stephen Peter East; Brian W. Dymock; Mark J. Gemkow; Andreas Kahrs; Andreas Ebneth; Sabine Löbbe; Kathy O’Shea; Daw-Tsun Shih; David S. Thomson

A high-throughput screening campaign resulted in the discovery of a highly potent dual cannabinoid receptor 1 (CB1) and 2 (CB2) agonist. Following a thorough SAR exploration, a series of selective CB2 full agonists were identified.


Archive | 2007

Compounds Which Modulate The CB2 Receptor

Angela Berry; Pier F. Cirillo; Eugene R. Hickey; Doris Riether; David S. Thomson; Renee M. Zindell; Nigel James Blumire; Chandana Chowdhury; Monika Ermann; James Edward Jenkins; Innocent Mushi; Christopher Francis Palmer; Malcolm Taylor


Archive | 2009

Compounds which selectively modulate the cb2 receptor

Alessandra Bartolozzi; Angela Berry; Eugene R. Hickey; Markus Ostermeier; Doris Riether; Achim Sauer; David S. Thomson; Lifen Wu; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Stephen Peter East; Monika Ermann; Someina Khor; Innocent Mushi


Archive | 2009

Amine and Ether Compounds Which Modulate The CB2 Receptor

Pier F. Cirillo; Eugene R. Hickey; Doris Riether; Monika Ermann; Innocent Mushi


Archive | 2009

Sulfonyl compounds which selectively modulate the CB2 receptor

Alessandra Bartolozzi; Angela Berry; Eugene R. Hickey; Markus Ostermeier; Doris Riether; Achim Sauer; David S. Thomson; Lifen Wu; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Stephen Peter East; Monika Ermann; Someina Khor; Innocent Mushi


Archive | 2008

Arylsulfonamide compounds which modulate the cb2 receptor

David S. Thomson; Doris Riether; Renee M. Zindell; Eugene R. Hickey; Monika Ermann; James Edward Jenkins; Innocent Mushi; Malcolm Taylor; Patricia Amouzegh; Edward Walker


Archive | 2011

Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor

Alessandra Bartolozzi; Angela Berry; Eugene R. Hickey; Markus Ostermeier; Doris Riether; Achim Sauer; David S. Thomson; Lifen Wu; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Stephen Peter East; Monika Ermann; Someina Khor; Innocent Mushi


Archive | 2010

Composés à modulation sélective du récepteur cb2

Alessandra Bartolozzi; Doris Riether; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Monika Ermann; Robert John Scott; Innocent Mushi


Archive | 2010

Verbindungen für selektive cb2-rezeptormodulation

Alessandra Bartolozzi; Doris Riether; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Monika Ermann; Robert John Scott; Innocent Mushi


Archive | 2009

Composés modulant sélectivement le récepteur cb2

Alessandra Bartolozzi; Angela Berry; Eugene R. Hickey; Markus Ostermeier; Doris Riether; Achim Sauer; David S. Thomson; Lifen Wu; Renee M. Zindell; Patricia Amouzegh; Nigel James Blumire; Stephen Peter East; Monika Ermann; Someina Khor; Innocent Mushi

Collaboration


Dive into the Innocent Mushi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge